Changes in treatment of community-onset Clostridioides difficile infection after release of updated guidelines, Atlanta, Georgia, 2018

Max W. Adelman; Dana Goodenough; Samantha Sefton; Carolyn Mackey; Stepy Thomas; Scott K. Fridkin; Michael H. Woodworth

doi:10.1016/j.anaerobe.2021.102364

Changes in treatment of community-onset Clostridioides difficile infection after release of updated guidelines, Atlanta, Georgia, 2018

Max W. Adelman, Dana Goodenough, Samantha Sefton, Carolyn Mackey, Stepy Thomas, Scott K. Fridkin, Michael H. Woodworth

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Updated Clostridioides difficile infection (CDI) guidelines published in 2018 recommend vancomycin as first-line treatment. Of 833 community-onset CDI cases in metropolitan Atlanta, Georgia in 2018, over half did not receive first-line treatment, although guideline adherence increased over the year. Second-line treatment was more common in patients treated in ambulatory settings.

Original language	English (US)
Article number	102364
Journal	Anaerobe
Volume	70
DOIs	https://doi.org/10.1016/j.anaerobe.2021.102364
State	Published - Aug 2021

Keywords

Clostridioides difficile infection
Guideline-adherent treatment
Metronidazole
Vancomycin

ASJC Scopus subject areas

Microbiology
Infectious Diseases

Access to Document

10.1016/j.anaerobe.2021.102364

Cite this

@article{7772ac0aa30f4b76ab8a4da0cadf9dbc,

title = "Changes in treatment of community-onset Clostridioides difficile infection after release of updated guidelines, Atlanta, Georgia, 2018",

abstract = "Updated Clostridioides difficile infection (CDI) guidelines published in 2018 recommend vancomycin as first-line treatment. Of 833 community-onset CDI cases in metropolitan Atlanta, Georgia in 2018, over half did not receive first-line treatment, although guideline adherence increased over the year. Second-line treatment was more common in patients treated in ambulatory settings.",

keywords = "Clostridioides difficile infection, Guideline-adherent treatment, Metronidazole, Vancomycin",

author = "Adelman, \{Max W.\} and Dana Goodenough and Samantha Sefton and Carolyn Mackey and Stepy Thomas and Fridkin, \{Scott K.\} and Woodworth, \{Michael H.\}",

note = "Publisher Copyright: {\textcopyright} 2021 Elsevier Ltd",

year = "2021",

month = aug,

doi = "10.1016/j.anaerobe.2021.102364",

language = "English (US)",

volume = "70",

journal = "Anaerobe",

issn = "1075-9964",

publisher = "Academic Press",

}

TY - JOUR

T1 - Changes in treatment of community-onset Clostridioides difficile infection after release of updated guidelines, Atlanta, Georgia, 2018

AU - Adelman, Max W.

AU - Goodenough, Dana

AU - Sefton, Samantha

AU - Mackey, Carolyn

AU - Thomas, Stepy

AU - Fridkin, Scott K.

AU - Woodworth, Michael H.

PY - 2021/8

Y1 - 2021/8

N2 - Updated Clostridioides difficile infection (CDI) guidelines published in 2018 recommend vancomycin as first-line treatment. Of 833 community-onset CDI cases in metropolitan Atlanta, Georgia in 2018, over half did not receive first-line treatment, although guideline adherence increased over the year. Second-line treatment was more common in patients treated in ambulatory settings.

AB - Updated Clostridioides difficile infection (CDI) guidelines published in 2018 recommend vancomycin as first-line treatment. Of 833 community-onset CDI cases in metropolitan Atlanta, Georgia in 2018, over half did not receive first-line treatment, although guideline adherence increased over the year. Second-line treatment was more common in patients treated in ambulatory settings.

KW - Clostridioides difficile infection

KW - Guideline-adherent treatment

KW - Metronidazole

KW - Vancomycin

UR - https://www.scopus.com/pages/publications/85105468295

UR - https://www.scopus.com/inward/citedby.url?scp=85105468295&partnerID=8YFLogxK

U2 - 10.1016/j.anaerobe.2021.102364

DO - 10.1016/j.anaerobe.2021.102364

M3 - Article

C2 - 33862203

AN - SCOPUS:85105468295

SN - 1075-9964

VL - 70

JO - Anaerobe

JF - Anaerobe

M1 - 102364

ER -

Changes in treatment of community-onset Clostridioides difficile infection after release of updated guidelines, Atlanta, Georgia, 2018

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this